Fitch Replaces Rating Process Documents

NEW YORK--(BUSINESS WIRE)-- Fitch Ratings has updated its special report 'The Ratings Process' (March 30, 2015) describing its credit rating process, criteria development and model management. This report is intended to increase investors' understanding of how Fitch rates corporate and structured finance entities.

Fitch has also withdrawn its 'Criteria for Reviewing Unique or Complex Transactions' (Aug. 14, 2014) and 'Managing and Developing Criteria and Models' (Jan. 30, 2015). These documents will be maintained as internal procedures going forward.

The full report, 'The Ratings Process,' is available at 'www.fitchratings.com', or by clicking on the link.

Additional information is available at 'www.fitchratings.com'.

Applicable Criteria and Related Research:

The Ratings Process (The Ratings Process under Fitch Criteria)

http://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=863980

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.

Fitch Ratings
Jeremy Carter
Managing Director
+44 20 3530 1391
Fitch Ratings
30 North Colonnade, Canary Wharf
London E14 5GN
United Kingdom
or
Media Relations:
Sandro Scenga, New York, +1 212-908-0278
Email: [email protected]

Source: Fitch Ratings

You May Also Be Interested In

• Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and
• Binance Coin Price Holds $730 After 1.6M Burn as Buyers Bet Pepeto Can Be the Next BNB
• New Creative Resource Helps Teams Plan AI Video and Image Workflows More Effectively